Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis (May 2000)

Annals of the Rheumatic Diseases

Volumn 59, Issue SUPPL. 1, 2000, Pages

  Furst, D E ^a   Klareskog, L G ^a   Lipsky, P E ^a   Maini, R N ^a   Russell, A S ^a   Scott, D L ^a   Smolen, J S ^a   Van de Putte, L B A ^a   Visher, T L ^a   Weisman, M H ^a   Breedveld, F C ^a   Burmester, G R ^a   Crofford, J J ^a   Emery, P ^a   Feldmann, M ^a   Kalden, J R ^a   Kavanaugh, A F ^a   Keystone, E C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; METHOTREXATE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG WITHDRAWAL; HUMAN; LUPUS ERYTHEMATOSUS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT INDICATION;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 19244372225     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (11)

1. Infliximab: A review of its use in the management of RA
2. Etanercept: Therapeutic use in patients with RA
3. Therapeutic efficacy of multiple intravenous infusions of anti-tumour necrosis factor (alpha) monoclonal antibody versus placebo in RA patients receiving concomitant methotrexate: A randomized phase III trial
4. Treatment of RA with a recombinant human tumour necrosis factor receptor (p75)-Fc fusion protein
5. Etanercept in children with polyarticular juvenile rheumatoid arthritis
6. A phase III trial of etanercept vs methotrexate in early RA
7. Long term treatment with the fully human anti-TNF Antibody D2E7 shows radiographic disease progression in RA
8. 54 week clinical and radiographic results from the ATTRACT Trial: A phase III study of infliximab in patients with active RA despite methotrexate
9. Etanercept in patients with psoriatic arthritis and psoriasis